产品编号：P139901
产品规格：10mg
产品价格：面议
| 标准品编号: | P139901 |
| 名称: | Palbociclib-d4 |
| 别名: | 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one-d4; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one-d4; Ibrance-d4; PD 0332991-d4; PD 332991-d4; PD 991-d4 |
| 参考CAS号: | Unlabelled: 571190-30-2 |
| 分子式: | C₂₄H₂₅D₄N₇O₂ |
| 外观: | Light Yellow Solid |
| 熔点: | >233°C (dec.) |
| 分子量: | 451.56 |
| 储存: | 冰箱 |
| 溶解度: | DMSO (Slightly, Heated), Methanol (Slightly, Heated) |
| 类别: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Palbociclib-d4 is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| 参考文献 | |
